- DSpace Home
- →
- Otras Comunidades
- →
- Cardiología
- →
- Browsing Cardiología by Title
- Políticas del Repositorio
- Contacto y sugerencias
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Cardiología by Title
Now showing items 10-29 of 37
-
(Nature Publishing Company, 2022-12)The EMPEROR-Preserved trial showed that the sodium-glucose co-transporter 2 inhibitor empagliflozin significantly reduces the risk of cardiovascular death or hospitalization for heart failure (HHF) in heart failure patients ...
-
(Bioexcel Publishing Ltd., 2023-01-04)Circulatory support with extracorporeal membrane oxygenation (ECMO) is being increasingly used in several critical situations but evidence of its impact on outcomes is inconsistent. Understanding of the specific indications ...
-
(Bioexcel Publishing, 2023-01-04)ne of the most relevant and differentiating aspects provided by the 2021 European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure is the retraction of the historical ...
-
(Bioexcel Publishing Ltd, 2023-01-04)Point-of-care ultrasound (POCUS) plays a strategic role in the diagnostic and therapeutic evaluation of critically ill patients and, especially, in those who are haemodynamically unstable. In this context, POCUS allows a ...
-
(Bioexcel Publishing, 2023-01-04)Tachycardia-induced cardiomyopathy is an entity characterized by reversible dysfunction of the left ventricle, which can be induced by different types of arrhythmia such as atrial fibrillation, atrial flutter, incessant ...
-
(Bioexcel Publishing, 2023-01-04)The nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway is dysregulated in patients with heart failure (HF) resulting in myocardial and vascular dysfunction that contributes to ...
-
(Massachusetts Medical Society, 2021-08-27)Background: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure ...
-
(Servier, 2021)Resumen no disponible
-
(Wiley, 2019-09-16)Background: The principal biological processes that characterize heart failure with a preserved ejection fraction (HFpEF) are systemic inflammation, epicardial adipose tissue accumulation, coronary microcirculatory ...
-
(Instituto Nacional de Cardiología Ignacio Chávez, 2020-12-16)
-
(Sociedad Interamericana de Cardiología, 2022)
-
(Comité de Insuficiencia Cardíaca de la Federación Argentina de Cardiología, 2020-06-24)La afectación de la infección por SARS-CoV-2 en el personal de salud constituye un serio problema para el control de los efectos de la pandemia. El contagio del personal de salud constituye no sólo un riesgo para los ...
-
(Sociedad Argentina de Cardiología, 2020-03)El síncope vasovagal (SVV) es altamente prevalente en la población general. Si bien su pronóstico es benigno en ciertos casos implica un mayor riesgo de traumatismos, así como un deterioro de la calidad de vida. El tratamiento ...
-
(Fundación Argentina de Cardiología, 2021-02-14)La enfermedad por coronavirus 2019 (CoViD-19) está causada por el virus del síndrome respiratorio agudo severo por coronavirus 2 (SARS-CoV-2), siendo particularmente perjudicial para los pacientes con enfermedad cardiovascular ...
-
(Sociedad Argentina de Cardiología, 2020-11)
-
(Elsevier, 2023-02-24)Immunizations for influenza and pneumococcus are effective interventions in reducing morbidity and mortality. The objective of this study was to describe the vaccination rates in volunteers from three regions of Argentina ...
-
(Colegio Argentino de Cirujanos Cardiovasculares, 2023-09-12)Antecedentes y objetivos: El objetivo de este trabajo es analizar la incidencia de isquemia medular (IM) e identificar los factores que contribuyen a su desarrollo durante la reparación endovascular de la aorta torácica ...
-
(Fundación Revista Medicina, 2021-02-10)La hipertensión arterial pulmonar (HAP) requiere procesos estructurados de diagnóstico y estratificación de riesgo, siendo la función del ventrículo derecho (VD) un marcador pronóstico central. Los principales objetivos ...
-
Manifestaciones pulmonares y sistémicas de la hipertensión arterial pulmonar. Un enfoque panvascular (Federación Argentina de Cardiología, 2021-03-10)La hipertensión arterial pulmonar (HAP) es una grave enfermedad cuyo resultado final de la interacción entre el tono vascular y la alteración progresiva de la remodelación de las arterias pulmonares provoca insuficienci ...
-
(Elsevier, 2023-12-01)Background: Multimorbidity (two or more comorbidities) is common among patients with acute heart failure, but comprehensive global information on its prevalence and clinical consequences across different world regions and ...
Now showing items 10-29 of 37
Atribución 4.0 Internacional (CC BY 4.0)